Stay updated on CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial

Sign up to get notified when there's something new on the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The completed CTX001 study’s results status changed to indicate that results have been submitted; the page revision also advanced from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T01:50:38.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the CTX001 transfusion-dependent β-thalassemia study is displayed, with details on its completed status, treatment and outcome measures, eligibility criteria, and study locations.
    Difference
    53%
    Check dated 2026-11-11T00:27:18.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0; the study record remains inaccessible with a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:16:02.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    An NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, which still displays a 403 Forbidden error. The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:37:18.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T22:59:45.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the usual study record content with an access-denied screen, including a 403 header and Home link; the previous study details and related sections are no longer visible.
    Difference
    18%
    Check dated 2026-09-22T23:03:06.000Z thumbnail image

Stay in the know with updates to CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page.